Bakhu Holdings, Corp. Reports Earnings Results for the Second Quarter Ended January 31, 2020
March 16, 2020 at 04:32 pm EDT
Share
Bakhu Holdings, Corp. announced earnings results for the second quarter ended January 31, 2020. For the second quarter, the company announced operating loss was USD 70,438 compared to Operating Income - AR of USD 0 a year ago. Net loss was USD 73,481 compared to USD 334 a year ago. For the half year, operating loss was USD 102,745 compared to USD 122,002 a year ago. Net loss was USD 108,213 compared to USD 122,670 a year ago.
Bakhu Holdings, Corp. is a development-stage company. The Company hold a license from Cell Science to plant cell-extraction and replication technology and related equipment, processes, and formulations (the Licensed Science), to produce, manufacture, and sell cannabis-related byproducts - sometimes referred to as cannabinoids in North America, Central America, and the Caribbean for medical, food additive, and recreational uses. The Company is focused on testing and commercializing cannabis plant cell-extraction and replication technologies under a technology license granted by Cell Science. It also intends to sublicense the Licensed Science to third party sub-licensees. The Company has not generated any revenue.
BAKHU HOLDINGS, CORP. 
